PerkinElmer produces and distributes ultra-pure Yttrium-90 radionuclide, which is extracted from Strontium-90 using a patented process licensed exclusively to PerkinElmer. Every lot of Yttrium-90 is...read more
PerkinElmer produces and distributes ultra-pure Yttrium-90 radionuclide, which is extracted from Strontium-90 using a patented process licensed exclusively to PerkinElmer. Every lot of Yttrium-90 is quality tested to ensure consistency. Documentation of test results at release, such as the ICP analysis for metals contamination, is provided with each shipment.
Based on its high purity and concentration, NEN® brand Yttrium-90 radionuclide is being combined with various monoclonal antibodies and peptides to create potential "Smart Drugs" which specifically target a number of cancers. This promising therapeutic application is currently being investigated in clinical trials for treating cancers such as ovarian, lung, breast, colon, prostate, brain, and non-Hodgkin's lymphoma. Through its worldwide distribution capabilities, PerkinElmer can assure delivery of this radioisotope to many areas of the world soon after production.
Write a review
Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad air (All reviews published will be entered into the next drawing on March 30th 2014).
Join the Global SelectScience Community Today! It’s FREE!
Helping you make informed decisions about the latest lab products and technologies:
Be the first to learn about new technologies
10,000+ trusted product reviews from your peers
Compare 500,000 products and manufacturers
Get exclusive buying tips from experts
Find solutions fast: 10,000+ Application Notes, Webinars and Videos
Connect with 250,000 scientists... All in one place!